{
  "id": "63f03155f36125a426000019",
  "type": "yesno",
  "question": "Was DNX-2401 tested for treatment of Diffuse Intrinsic Pontine Glioma?",
  "ideal_answer": "Yes. DNX-2401 is tested for treatment of Diffuse Intrinsic Pontine Glioma.",
  "documents": [
    "http://www.ncbi.nlm.nih.gov/pubmed/24718705",
    "http://www.ncbi.nlm.nih.gov/pubmed/29088386",
    "http://www.ncbi.nlm.nih.gov/pubmed/29594041",
    "http://www.ncbi.nlm.nih.gov/pubmed/35767439"
  ],
  "snippets": [
    {
      "text": "Oncolytic DNX-2401 Virus for Pediatric Diffuse Intrinsic Pontine Glioma.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/35767439",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": "METHODS: We conducted a single-center, dose-escalation study of DNX-2401, an oncolytic adenovirus that selectively replicates in tumor cells, in patients with newly diagnosed DIPG. ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/35767439",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "CONCLUSIONS: Intratumoral infusion of oncolytic virus DNX-2401 followed by radiotherapy in pediatric patients with DIPG resulted in changes in T-cell activity and a reduction in or stabilization of tumor size in some patients but was associated with adverse events.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/35767439",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Phase I Trial of DNX-2401 for Diffuse Intrinsic Pontine Glioma Newly Diagnosed in Pediatric Patients.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/29088386",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": "OBJECTIVE: To determine the safety, tolerability, and toxicity of an oncolytic adenovirus, DNX-2401, injected into the cerebellar peduncle in pediatric subjects with DIPG and to collect tumor samples of this type of tumor.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/29088386",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "DNX-2401, an Oncolytic Virus, for the Treatment of Newly Diagnosed Diffuse Intrinsic Pontine Gliomas: A Case Report.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/29594041",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": "To this aim, we have designed a clinical Phase I trial for newly diagnosed pediatric DIPG to investigate the feasibility, safety, and preliminary efficacy of delivering DNX-2401 into tumors within the pons following biopsy.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/29594041",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": " To our knowledge, this is the first report of intratumoral DNX-2401 for a patient with DIPG in a clinical trial. ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/29594041",
      "beginSection": "abstract",
      "endSection": "abstract"
    }
  ],
  "concepts": [],
  "exact_answer": "Yes"
}